- Q1 142 %38.0
- Q2 120 %32.1
- Q3 91 %24.3
- Q4 21 %5.6
Academician
SERCAN AKSOY
PROFESÖR
HACETTEPE ÜNİVERSİTESİ KANSER ENSTİTÜSÜ KLİNİK ONKOLOJİ ANABİLİM DALI
Research topics OpenAlex
- Cancer Immunotherapy and Biomarkers76
- HER2/EGFR in Cancer Research68
- Breast Cancer Treatment Studies67
- Cancer Treatment and Pharmacology66
- Advanced Breast Cancer Therapies64
- Inflammatory Biomarkers in Disease Prognosis49
- Head and Neck Cancer Studies47
- Gastric Cancer Management and Outcomes46
- Chemotherapy-induced cardiotoxicity and mitigation42
- Radiopharmaceutical Chemistry and Applications37
- Bone health and treatments28
- Lung Cancer Research Studies28
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Academic summary
YÖKSİS and OpenAlex counted separately.
Articles
531
YÖKSİS531
OpenAlex0
Projects
42
Books
14
Proceedings
609
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 269
h-index
33
Percentile in Türkiye: 100
#35 of 2,315 at their university by h-index
- i10-index
- 132
- Total citations
- 5,497 Top 0.3% in Türkiye
- Per article
- 20.4
- FWCI
- 1.60 1.00 = world average
- World top 1%
- 5
- World top 10%
- 42
Most cited articles
- Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
- Trastuzumab deruxtecan versus treatment of physicians choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
- Rituximab related viral infections in lymphoma patients
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #8/ 43,834 top 0.0% At university #1/ 1,066Score 346.95 journal 340.2 · OA add 6.75
- Article rank10/43,834
- Scopus rank10/43,834
- WoS rank10/43,834
- YÖKSİS535
- Scopus376
- WoS383
-
Side field Tıbbi Onkoloji (İç Hastalıkları)Points rank #1/ 318 top 0.3% At university #1/ 13Score 346.95 journal 340.2 · OA add 6.75
- Article rank2/318
- Scopus rank2/318
- WoS rank2/318
- YÖKSİS535
- Scopus376
- WoS383
Index quartiles
?- Q1 90 %23.6
- Q2 58 %15.2
- Q3 122 %31.9
- Q4 112 %29.3
Top 1%7
Top 10%106
Avg · n 659
%66.7
Other counts
Scopus (SJR)
- Excluding abstracts 368 Q1 139 Q2 120 Q3 91 Q4 20
- Best Q 372 Q1 142 Q2 119 Q3 90 Q4 21
- YÖKSİS rows 789
WoS (JCR)
- Excluding abstracts 374 Q1 87 Q2 58 Q3 122 Q4 111
- Best Q 378 Q1 90 Q2 57 Q3 121 Q4 110
- YÖKSİS rows 793
TR Index
- Excluding abstracts 33 articles
- YÖKSİS rows 55 articles
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
145 journals
- Journal of B.U.ON. 39
- Medical Oncology 31
- Asian Pacific Journal of Cancer Prevention 22
- Breast 12
- Current Medical Research and Opinion 12
- UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi 12
- ISSN 2241-6293 9
- Future Oncology 9
- Supportive Care in Cancer 8
- Annals of Oncology 7
- International Journal of Cancer 7
- Journal of Clinical Medicine 7
- Southern Medical Journal 7
- BMC Cancer 6
- Journal of Clinical Oncology 6
- Turkish Journal of Medical Sciences 6
- Breast Journal 5
- Leukemia and Lymphoma 5
- Acta Oncologica 4
- BMJ Supportive and Palliative Care 4
- Cancer Research 4
- Expert Review of Anticancer Therapy 4
- Hepato-Gastroenterology 4
- Indian Journal of Cancer 4
- World Journal of Gastroenterology 4
- American Journal of Hematology 3
- Cancer Chemotherapy and Pharmacology 3
- Cancers 3
- European Archives of Oto-Rhino-Laryngology 3
- Immunotherapy 3
- International Journal of Clinical Oncology 3
- Journal of Neuro-Oncology 3
- Journal of Oncological Science 3
- Journal of Oncology Pharmacy Practice 3
- Medical Hypotheses 3
- Microchemical Journal 3
- Nature Communications 3
- ISSN 0141-9854 2
- ISSN 2168-8184 2
- Acta Medica Mediterranea (discontinued) 2
- Annals of Pharmacotherapy 2
- Biomarkers in Medicine 2
- Cancer Treatment Reviews 2
- Chemotherapy 2
- Frontiers in Oncology 2
- Journal of Cancer Research and Therapeutics 2
- Journal of Chemotherapy 2
- Journal of Endocrinological Investigation 2
- Journal of the National Medical Association 2
- Lung Cancer 2
- Medicine (United States) 2
- Molecular and Clinical Oncology 2
- Neoplasma 2
- New England Journal of Medicine 2
- Pain Medicine (United States) 2
- Prostate 2
- Rheumatology International 2
- Strahlentherapie und Onkologie 2
- Tumori 2
- Turkish Journal of Cancer 2
- Urologic Oncology: Seminars and Original Investigations 2
- ISSN 0304-596X 1
- 1070625 1
- ISSN 1198-0052 1
- ISSN 1300-1744 1
- ISSN 2020-0024 1
- ISSN 2021-0031 1
- ISSN 2021-0303 1
- ISSN 2147-9488 1
- ISSN 2148-2357 1
- ISSN 2148-7758 1
- ISSN 2149-5254 1
- ISSN 2165-7386 1
- ISSN 2465-9652 1
- ISSN 2553-6594 1
- ISSN 2641-6043 1
- ISSN 2667-7849 1
- ISSN 2717-7505 1
- 284186x 1
- ISSN 3447-2040 1
Showing the first 80 journals (145 in total).
Narrow down
Article filter applied. Journal filter: Current Medical Research and Opinion Clear filter ×
Article list
- 2024 The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional study YÖKSİS SJR Q2 JCR Q2 OpenAlex 62.1%
- 2017 Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study YÖKSİS SJR Q1 JCR Q1
- 2016 A comprehensive review of denosumab for bone metastasis in patients with solid tumors YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 93.5%
- 2016 Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study YÖKSİS SJR Q1 JCR Q1
- 2016 Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.0%
- 2015 Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2 positive early breast cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.3%
- 2014 The efficacy of adjuvant trastuzumab in HER 2 positive breast cancer with axillary lymph node metastases according to the treatment duration YÖKSİS SJR Q1 JCR Q1 OpenAlex 70.3%
- 2014 Current approaches for prophylactic cranial irradiation in extrapulmonary small cell carcinoma YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.4%
- 2013 Cardiotoxicity of novel HER2 targeted therapies YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.2%
- 2013 Trastuzumab emtansine T DM1 for HER2 positive breast cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.3%
- 2013 Everolimus a new hope for patients with breast cancer YÖKSİS SJR Q1 JCR Q1
- 2012 Pertuzumab in HER2 positive breast cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 90.0%